Gene · 8648
Papers3,138
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,138
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biphenotypic Sinonasal Sarcoma with Orbital and Skull Base Involvement Report of 3 Cases and Systematic Review of the Literature. | Indian J Otolaryngol Head Neck Surg | 2023 | 38027532 | PubTator, text mining | PubMed |
| Breast cancer therapies reduce risk of Alzheimer's disease and promote estrogenic pathways and action in brain. | iScience | 2023 | 38026173 | PubTator, text mining | PubMed |
| Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders. | Cell Biosci | 2023 | 38017588 | PubTator, text mining | PubMed |
| An encyclopedia of enhancer-gene regulatory interactions in the human genome. | bioRxiv | 2023 | 38014075 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review. | Biomolecules | 2023 | 38002328 | PubTator, text mining | PubMed |
| The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer's Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue. | Antioxidants (Basel) | 2023 | 38001775 | PubTator, text mining | PubMed |
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). | Clin Kidney J | 2023 | 37915899 | PubTator, text mining | PubMed |
| SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances. | Front Oncol | 2023 | 37909026 | PubTator, text mining | PubMed |
| ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer. | Epigenetics | 2023 | 37908128 | PubTator, text mining | PubMed |
| Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan. | BMC Cancer | 2023 | 37904096 | PubTator, text mining | PubMed |
| Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments. | Cancers (Basel) | 2023 | 37894414 | PubTator, text mining | PubMed |
| Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease. | Biomedicines | 2023 | 37893070 | PubTator, text mining | PubMed |
| The N221D variant in PCSK1 is highly prevalent in childhood obesity and can influence the metabolic profile. | J Pediatr Endocrinol Metab | 2023 | 37877373 | PubTator, text mining | PubMed |
| OSR1 disruption contributes to uterine factor infertility via impaired Müllerian duct development and endometrial receptivity. | J Clin Invest | 2023 | 37847567 | PubTator, text mining | PubMed |
| Prevalence of genetic causes of obesity in clinical practice. | Obes Sci Pract | 2023 | 37810530 | PubTator, text mining | PubMed |
| Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis. | medRxiv | 2023 | 37808834 | PubTator, text mining | PubMed |
| Circadian clock crosstalks with autism. | Brain Behav | 2023 | 37807632 | PubTator, text mining | PubMed |
| Cellular specificity of lactate metabolism and a novel lactate-related gene pair index for frontline treatment in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37795453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8648/papers?page=6